Log In
BCIQ
Print this Print this
 

AUNP12

  Manage Alerts
Collapse Summary General Information
Company Aurigene Discovery Technologies Ltd.
DescriptionA programmed cell death 1 (PDCD1; PD-1; CD279) peptide antagonist
Molecular Target Programmed cell death 1 (PD-1) (PDCD1) (CD279)
Mechanism of ActionProgrammed cell death 1 (PD-1) antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerLaboratoires Pierre Fabre S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/17/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today